Inner Mongolia Kangpu Pharmaceutical Co., LTD

Company Profile
Inner Mongolia Kangpu Pharmaceutical Co., LTD
Inner Mongolia Kangpu Pharmaceutical Co.,LTD.,funded by Changzhou Kangpu Pharmaceutical Co.,LTD.,was established in July 2019 with a registered capital of 250 million yuan.It is a pharmaceutical high-tech enterprise integrating research and development,production and sales.Production scope:16 non-sterile apis,such as Difenoxate hydrochloride,atropine sulfate, phenhyxol hydrochloride,phenbromarone hydrochloride,aminotoluene acid, pyrithione sodium,chlorpromazine hydrochloride,lidocaine hydrochloride,propranolol hydrochloride,promethazine hydrochloride,sulapride,dipyridamole,metoxlopramide, amsulpiride sulfate,salbutamol sulfate,acotidine hydrochloride,etc.It involves six categories including psychiatry,digestive tract,cardiovascular,antihistamine,antipyretic and analgesic,and nervous system.
more >

Year of Establishment:

Total Assets(USD):

Total Number of Staff:

Main Competitive Advantages:

Other Competitive Advantages:

Patents and Copyrights:

Send your message to this supplier
  • From:
  • To:
    Inner Mongolia Kangpu Pharmaceutical Co., LTD
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service